Maj bank Image empty


KabaFusion is a home infusion company that excels in its approach to patient care and clinical outcomes. KabaFusion’s intravenous therapies for patients with chronic conditions reduce the need for hospital stays. By enabling home-based care, the company increases accessibility and affordability for patients; improves treatment comfort for patients; and alleviates pressure on hospital resources.

Investment rationale

The home intravenous immunoglobulin market is growing fast, driven by cost effectiveness, patient and payer preferences, and new indications. KabaFusion has organically grown 3x the market in the past 8 years. 

Headquarters: Massachusetts, USA


Fund: MIM I


Year of investment


Maj bank Image empty